Core Insights - Exousia Pro, Inc. has launched its flagship nutraceutical product, Maxasome™, which is based on proprietary exosome-based delivery systems [1] - Maxasome™ is derived from 100% pure Exosome-Like Nanoparticles (ELNs) sourced from the Yellow Oyster Mushroom, known for its high value [1] - The product is designed as a multi-modal cytoprotective agent aimed at enhancing cellular defense and extending health span [1] Company Overview - Exousia Pro, Inc. is a clinical-stage biotechnology company focused on innovative delivery systems utilizing exosomes [1] - The company emphasizes the all-natural composition of its products, highlighting the use of ELNs from a specific mushroom species [1] Product Details - Maxasome™ is characterized as an unprecedented nutraceutical, indicating a unique position in the market [1] - The product aims to provide unparalleled cellular defense, suggesting a strong potential for health benefits [1]